Melinta Therapeutics has granted Italy’s Menarini Group exclusive rights to commercialize Delafloxacin (known as Baxdela in the US), an investigational anionic fluoroquinolone, under their own brands in 68 countries​ … more

Separately, the FDA has accepted an Investigational New Drug application from Melinta for topical radezolid for the treatment of mild-to-moderate acne … more